Atlas Trials

Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT01913951 · COMPLETED

Trial details

NCT number
NCT01913951
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2013-11-22
Primary completion
2016-12-05
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.